Ad
related to: retacrit vs epogen dosing
Search results
Results from the WOW.Com Content Network
Epoetin alfa, sold under the brand name Epogen among others, is a human erythropoietin produced in cell culture using recombinant DNA technology. [ 8 ] [ 9 ] Epoetin alfa is an erythropoiesis-stimulating agent. [ 8 ]
Methoxy polyethylene glycol-epoetin beta (Mircera) by Roche [20] epoetin delta: Dynepo trademark name for an erythropoiesis stimulating protein, by Shire plc [21] epoetin omega: Epomax; epoetin zeta (biosimilar forms for epoetin alpha): Silapo (STADA Arzneimittel AG) [22] Retacrit (Hospira, Pfizer Europe MA EEIG) [23] Miscellaneous:
n/a n/a Ensembl n/a n/a UniProt n a n/a RefSeq (mRNA) n/a n/a RefSeq (protein) n/a n/a Location (UCSC) n/a n/a PubMed search n/a n/a Wikidata View/Edit Human Erythropoietin (/ ɪ ˌ r ɪ θ r oʊ ˈ p ɔɪ. ɪ t ɪ n, - r ə -, - p ɔɪ ˈ ɛ t ɪ n, - ˈ iː t ɪ n / ; EPO), also known as erythropoetin, haematopoietin, or haemopoietin, is a glycoprotein cytokine secreted mainly by the kidneys ...
According to Roche, the product has the longest half-life of all FDA-approved erythropoiesis-stimulating agents (ESAs): up to 6 times longer than darbepoetin alfa and up to 20 times longer than epoetin. CERAs thus promise both lower dosing—significant owing to the high inherent cost of manufacturing recombinant protein drugs—and less ...
An equianalgesic chart is a conversion chart that lists equivalent doses of analgesics (drugs used to relieve pain). Equianalgesic charts are used for calculation of an equivalent dose (a dose which would offer an equal amount of analgesia) between different analgesics. [1]
The FDA determined that the data presented in a 2022 color additive petition show that this ingredient causes cancer in male laboratory rats exposed to high levels of FD&C Red No. 3 because of a ...
epoetin alfa-epbx/Retacrit: epoetin alfa/Procrit June 2018 [152] [153] pegfilgrastim-jmdb/Fulphila: pegfilgrastim/Neulasta July 2018 [154] filgrastim-aafi/Nivestym: filgrastim/Neupogen October 2018 [155] adalimumab-adaz/Hyrimoz: adalimumab/Humira November 2018 [156] pegfilgrastim-cbqv/Udenyca: pegfilgrastim/Neulasta November 2018 [157 ...
GLP-1 vs. traditional diabetes drug users. For this study, researchers analyzed medical records from more than 2 million people taking diabetes medications, including over 215,000 who took GLP-1 ...
Ad
related to: retacrit vs epogen dosing